Call for Proposals: Supporting Local Advocacy Initiatives to Improve Access to Comprehensive, People-centered Harm Reduction Services

The Correlation-European Harm Reduction Network (C-EHRN), the Eurasian Harm Reduction Association (EHRA), the Drug Policy Network South East Europe (DPNSEE), and the European Network of People Who Use Drugs (EuroNPUD) are pleased to announce a call for proposals.

This initiative aims to support local advocacy efforts of community-led and civil society organizations in Europe, enhancing access to comprehensive, people-centered health and harm reduction services for people who use drugs in European countries. Applicants must be based in eligible countries, and proposed activities should align with the advocacy priorities stated in this call.

Awarded grantees will receive:

  • ongoing mentorship support;
  • the opportunity to participate in advocacy training, and;
  • grant of €3,000 for organizing advocacy-related activities, including policy dialogue meetings and events at the local level.

Background Information

The HIV/AIDS and viral hepatitis epidemics pose a significant public health burden in Europe, disproportionately affecting people who use drugs and other vulnerable populations lacking access to health services. The BOOST is an EU-funded project responding to this challenge, aiming to strengthen community-based and community-led organizations in their efforts to implement effective and comprehensive health and harm reduction interventions for people who use drugs. This project involves four major European networks: EHRA, C-EHRN, DPNSEE, and EuroNPUD, along with other partners. For more information on the BOOST project, please visit:

In 2023, these four community networks conducted a series of virtual and face to face meetings, engaging over 100 members and experts in the field. These sessions aimed to identify key barriers and challenges faced by people who use drugs in accessing health and harm reduction services, and to explore solutions to overcome these challenges. The consultations facilitated discussions on relevant areas for advocacy to improve harm reduction services and HIV/HCV/HBV prevention, treatment, and care for people who use drugs at local and national levels.

The findings from these consultations supported the development of a Joint European Advocacy Strategy for the next five years (2024-2028), outlining the following four advocacy priorities:

Priority 1: Increase Political Will and Financial Sustainability for Community-Based Harm Reduction

Priority 2: Promote Community-Driven Harm Reduction Tailored to Diverse Needs

Priority 3: Ensure that people who use drugs have access to specific health services, including disease prevention and management, sexual health services, and testing and treatment for HIV, STIs, and Hepatitis B and C.

Priority 4: Ensure universal access to comprehensive health and social care for people who use drugs

Aims and objectives of the Programme

The Programme will support six local advocacy initiatives from community and civil society organizations to develop and implement local advocacy activities. These activities should enhance access to comprehensive, people-centered health and harm reduction services, covering one or more of the priority areas of the Joint European Advocacy Strategy.

Applicants will be provided with a grant of €3,000 and will commit to:

  • Develop and implement a local Advocacy Plan aligned with one or more of the priority areas.
  • Participate in one face-to-face Advocacy Workshop and a series of online mentorship meetings to support the development and implementation of the local Advocacy Plan.
  • Prepare a policy briefing paper with relevant policy recommendations to be disseminated among local and national policymakers.
  • Organize at least one policy dialogue meeting with relevant local and national policymakers and civil society representatives.
  • Document and report on the progress and results of the Advocacy Activities, based on a predefined Reporting Template.

Timeline to implement Advocacy Projects and Terms of Reference, Budget, and Payment Conditions

Local Advocacy initiatives should be tailored to local needs but must be completed before October 2025. Selected applicants will sign an Agreement outlining the Terms of Reference, a detailed overview of proposed activities, the budget, and the timeline. Each selected Advocacy Project will receive a grant of €3,000 to implement the Advocacy Plan, which includes the development and dissemination of a Policy Briefing Paper, the organization of at least one local Policy Dialogue Event (including national/local policymakers and civil society representatives), and the preparation of an Advocacy Report.

Please note that no advance payment will be made. Full payment will only be released once all activities have been completed. Exceptions can be discussed during the grant-making process.

Eligibility criteria for Applicants

Eligible applicants include NGOs, non-for-profit organizations, or initiative groups without official registration, with a preference for community-based and community-led services, located in one of the following countries: Albania, Bosnia and Herzegovina, Bulgaria, Montenegro, North Macedonia, Serbia, Kosovo Territory*, Greece, Croatia, Slovenia, Romania, Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Portugal, Spain, Sweden, Czech Republic, Estonia, Georgia, Hungary, Latvia, Lithuania, Moldova, Poland, Slovakia, Ukraine. Initiative groups may apply, but their financial agent should be an NGO or a non-for-profit organization.

Evaluation Process and Criteria

Submitted applications will be evaluated by an evaluation panel consisting of representatives from EHRA, C-EHRN, DPNSEE, and EuroNPUD. The networks will ensure that the different Advocacy projects are balanced in terms of geographical coverage and the different priority areas and include both community-based and community-led initiatives.

The applications will be evaluated based on the following criteria:

Evaluation Criteria


Alignment with advocacy priorities: Degree to which the proposal aligns with the stated advocacy priorities, including enhancing political support for harm reduction, expanding service accessibility, removing legal and policy barriers, and ensuring universal access to health and social care for people who use drugs.


Quality of the proposal: objectives, proposed activities and expected result need to be clearly described and must be consistent with each other.


Impact potential: Potential impact of the proposed initiative on improving access to comprehensive, people-centred harm reduction services, including the ability to address stigma, funding challenges, and integrate harm reduction into public health policies.


Feasibility and sustainability: Feasibility of the proposed advocacy activities, including the proposed timeline. c and sustainability and impact of the advocacy efforts.


Capacity and experience: Demonstrated capacity and experience of the applicant organisation in conducting advocacy and harm reduction initiatives, with a preference for community-based and community-led services with a track record of impactful work.


Diversity and inclusion: Consideration of diversity and inclusion in the proposal, ensuring that the initiative takes into account the diverse needs of PWUD and related populations, disproportionately affected by stigma, discrimination and health and social inequalities.


Budget justification: Clarity and justification of the budget proposal, clearly describing how the budget of €3,000 is spent and contributes to the achievement of the proposed objectives.


Maximum possible number of points


Support for selected advocacy projects 

Support during the implementation of local advocacy initiatives includes:

  • Participation in a face-to-face advocacy training workshop for all advocacy projects to improve advocacy skills, knowledge, and capacities. Specific sessions will be organized to enhance the quality and feasibility of the Draft Advocacy Plans. Follow-up steps and activities will be discussed and agreed upon.
  • Ongoing Mentorship Support from EHRA, C-EHRN, DPNSEE, and EuroNPUD in developing and implementing the local advocacy plans.
  • Support from EHRA, C-EHRN, DPNSEE, and EuroNPUD in preparing a policy briefing paper and organizing a local Policy Dialogue, including site visits of the related networks to enhance advocacy efforts by bringing a regional perspective, in which the Draft Advocacy Plans will be discussed and improved.
  • Support in preparing a local Advocacy Report, based on a predefined template to share successes, challenges, and lessons learned.
  • €3,000 to support the development and implementation of the advocacy plan, including the policy briefing paper and a Policy Dialogue Meeting.

Application Process

Interested organizations are invited to submit a proposal that includes:

  • Application form completed ONLINE including the following information:
  • Which advocacy priority areas are addressed by the advocacy project.
  • Organizational Information: objectives, position in the country, how the organization’s activities are linked to the priority areas of this call, organization’s experience in harm reduction and advocacy.
  • Detailed description of the proposed advocacy project, including:
  • A short background and rationale (why the project is needed).
  • The objectives of the Advocacy Project.
  • The proposed activities, including timeline.
  • The expected results.
  • A budget proposal and timeline.
  • Memorandum of cooperation or agreement (in case of working through a fiscal agent for unregistered initiatives or groups), uploaded to the application form.


  • Call for proposals opens: 5 March 2024
  • Submission deadline: 5 April 2024
  • Applications review process: 5 April to 15 April 2024 
  • Informing selected grantees: 19 April 2024
  • Project implementation period: 1 May 2024 to 31 October 2025


All application should be submitted in English language online using this FORM.

For questions or additional information, please contact


*This designation is without prejudice to positions on status and is in line with UNSC 1244 and the ICJ Opinion on the Kosovo Declaration of Independence.